SurfingBearHome › Blog › Healthcare AI adoption
What to check before adopting healthcare AI — the regulatory path comes first
This category is unlike any other. The regulatory pathway precedes the feature review, and without one, performance is irrelevant because the tool cannot be used in Korea.
Approval pathway Medical data Real product list
The short answer
This post makes no claim about any product’s clinical effect or diagnostic performance. Those claims belong to regulatory filings and the literature, and are not information a catalogue can carry.
What it does cover is the evaluation checklist: the Korean approval pathway, the lawful basis for medical data, whether the software is a medical device, and which areas — such as clinical documentation — carry lighter regulatory weight.
Candidates by use, with regulatory weight
| Use | Regulatory weight | Real products |
|---|---|---|
| Consultation to clinical note | Medium — documentation, not diagnosis | Abridge · Dragon Copilot |
| Patient data integration and analytics | Medium — data processing | Innovaccer |
| Imaging interpretation support | High — may be a medical device | Lunit · Qure.ai |
| Patient-facing interaction | Medium — safety standards required | Hippocratic AI |
What you must check
Start where the regulation is lighter
The fastest area to adopt in practice is documentation and administration, not diagnosis — writing up consultations, appointment and enquiry handling, paperwork, billing preparation.
Those involve no medical judgement, so medical device classification is unlikely, and the effect is immediately measurable. Documentation time is among the heaviest burdens on clinicians, so the felt benefit is large.
Interpretation support and diagnostic areas come after the approval position is confirmed. Keeping that order does not delay adoption; it avoids spending time on a tool you cannot use.
Frequently asked questions
If it has FDA clearance, can we use it in Korea?
Foreign clearance is not a basis for domestic use. Korea requires its own pathway, starting with whether the software is a medical device. Ask the vendor for the Korean approval status in writing.
Is a clinical documentation tool a medical device?
Documentation itself is generally not a diagnostic function, so the assessment differs. But if the product also offers diagnostic suggestions or risk scoring, the answer can change — establish the exact feature scope.
Can patient data go to overseas servers?
That is a cross-border transfer of sensitive data, and the requirements are strict. Check first whether domestic storage or on-premise options exist, and do not proceed without legal review.
How do we measure the effect?
For documentation, note-writing time per patient and residual admin time after clinic. Clinical performance is not something you measure at evaluation stage — that comes from regulatory filings and the literature.
Product list
Narrow the candidates
The AI product directory lists healthcare products. Each page organises published information; approval status must be confirmed with the vendor directly.